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Background
A recent large-scale clinical trial has indicated that an
initial invasive strategy does not improve cardiac outcomes
beyond optimized medical therapy in patients with stable
coronary artery disease (CAD). Therefore, novel methods
to stratify at-risk patients may refine therapeutic decisions
and improve outcomes. We sought to test the hypothesis
that stress cardiac magnetic resonance (CMR) imaging
effectively prognosticates and reclassifies patient risk in a
consecutive clinical cohort of patients with known or sus-
pected CAD across a spectrum of guideline-determined
risk categories.
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Methods
In a prospective observational study of 815 consecutive
patients clinically referred for stress CMR between
2001-2011, we studied the association of inducible
ischemia on a composite of cardiac mortality and acute
non-fatal myocardial infarction (MACE). We con-
structed Cox regression models to measure the indepen-
dent and incremental association of inducible ischemia
with our composite outcome beyond traditional markers
of risk (including prior CAD). In addition, we quantified
net reclassification improvement across guideline-based
3-year risk categories of MACE: low (<3%), moderate
(3-9%), and high (>9%) by inducible ischemia by CMR,
incremental to clinical risk models.
Results
Inducible ischemia was the strongest predictor of MACE
in the overall cohort and in patients with prior CAD
(hazard ratios 15.66 and 8.18, respectively; P<0.0001).
Absence of inducible ischemia was associated with low
annual rates of MACE and cardiac death (whole cohort,
0.6% and 0.4%; prior CAD, 1.3% and 0.6%, respectively).
Addition of inducible ischemia to the best clinical risk
model (age and prior CAD adjusted) improved discrimina-
tion of MACE (C-statistic 0.81 to 0.86; P<0.0001).
Inducible ischemia reclassified 91.5% of patients at moder-
ate pre-test risk (65.7% to low risk; 25.8% to high risk),
with corresponding changes in annual event rates (post-
test low risk, 0.3%/year; post-test high risk, 4.9%/year).
Categorical net reclassification index was 0.229 (95%
0.063-0.391). For patients with prior CAD, inducible ische-
mia reclassified 44% of patients at moderate pre-test risk
and 37% at high pre-test risk to lower post-test risk, with a
low annual rate of MACE (1.2%/year in both groups).
Conclusions
The presence and extent of inducible ischemia by stress
CMR effectively reclassifies patient risk beyond standard
clinical risk factors, specifically in patients at moderate-
to-high pre-test risk and in patients with prior CAD.
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Figure 2 Kaplan-Meier MACE-free survival curves for the whole cohort (A) and patients with prior CAD (B). Follow-up period was truncated to 8
years. The bottom graphs (C and D) displayed the corresponding cumulative hazard function (bottom panels) for illustration of rates of MACE
accumulation in these respective patient groups during the first 5 years after stress CMR assessment. P-value was derived using the log-rank test.
Abbreviations: ISCH = inducible ischemia by stress CMR.
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